XIU ETF Analysis: S&P/TSX 60 | TO

Canada Equity | TO, Canada | Market Cap: 23.205m CAD | 12M Return: 23% | CA46428D1087 | Charts, Fundamentals & Technical Analysis

Financials, Energy, Healthcare, Utilities
Total Rating 64
Safety 49
Buy Signal -0.30
Canada Equity
Category Rotation: -4.6
AUM: 16.4B
Avg Turnover: 249M
Risk 3d forecast
Volatility16.4%
VaR 5th Pctl3.09%
VaR vs Median4.89%
Reward TTM
Sharpe Ratio1.37
Rel. Str. IBD68.1
Rel. Str. Peer Group50 pctl
Character TTM
Beta0.471
Beta Downside0.417
Hurst Exponent0.485
Choppyness49.2%
Drawdowns 3y
Max DD12.36%
CAGR/Max DD1.99
CAGR/Mean DD19.56

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 11.8 years of data, until 10/2026

Jan -0.3% 0
Feb +0.0% 0
Mar -0.6% 4
Apr +1.8% 4
May +0.2% 14
Jun +0.1% 0
Jul +1.5% 14
Aug -0.5% 47
Sep -2.6% 4
Oct -0.1% 0
Nov +1.5% 39
Dec -1.4% 9

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: XIU S&P/TSX 60

The iShares S&P/TSX 60 Index ETF (XIU) seeks to track the S&P/TSX 60, providing exposure to 60 of the largest companies listed in Canada. Its holdings span sectors including financials, energy, utilities, healthcare and consumer staples, so the fund offers diversified exposure to large-cap Canadian businesses through a single ETF.

Headlines to Watch Out For
  • Canadian bank earnings and credit conditions steer index returns
  • Oil and metals price swings move energy and mining shares
  • Interest-rate shifts reshape utility valuations and dividend appeal
What is the price of XIU shares?

As of November 11, 2026, the stock is trading at CAD 54.35 with a total of 2,110,335 shares traded. Over the past week, the price has changed by +1.65%, over one month by +1.10%, over three months by +0.67% and over the past year by +22.95%.

Current recommended Stop Loss: 52.50 (which is 3.4% or 2.4 ATR below the current price).

Is XIU a buy, sell or hold?

S&P/TSX 60 has no consensus analysts rating.